###### Article summary

Strengths and limitations of this study
=======================================

-   First study to have assessed the impact of individual risk attitudes of physicians on antibiotic prescribing using a standardised measure scale.

-   Large nationwide representative sample of general practitioners.

-   Based on declarative data, and not on real practices, but standardised questions allowed us to assess the true impact of individual risk attitudes and clinical vignettes have been shown to be a valid tool for measuring the quality of physician practice.

Introduction {#s1}
============

Given the current worldwide bacterial resistance crisis, decreasing unnecessary use of antibiotic is crucial. In France, 80% of all antibiotics administered to humans are prescribed in the outpatient setting, and general practitioners (GPs) account for 71% of these prescriptions.[@R1]

Tonsillitis is one of the leading causes for prescribing antibiotics in the outpatient setting.[@R2] Rapid Antigen Diagnostic Tests (RADTs) detecting group A streptococcal infections offer a useful means to reduce unnecessary antibiotic prescriptions: the 2011 French guidelines recommend using these tests in all cases of tonsillitis in children ≥3 years and prescribing antibiotics only in proven group A streptococcal infections (positive RADT result).[@R3] If RADT is not available, the guidelines explicitly state that antibiotic therapy is not required.[@R3] However, in France, RADTs are underused for patients presenting with tonsillitis.[@R4]

Non-compliance with guidelines can be explained by a variety of factors.[@R5] At country level, 'uncertainty avoidance' was recently identified in multivariate analysis as one of the national cultural dimensions significantly associated with (inappropriate) use of antibiotics for colds/flu/sore throats,[@R6] confirming previous findings.[@R7] France is a country with a high uncertainty avoidance score.[@R6] [@R7] At the individual level, recent reviews of qualitative studies identified diagnostic uncertainty as an important factor favoring antibiotic misuse.[@R8] [@R9] Risk aversion slightly differs from uncertainty avoidance, but, as a close concept largely used in economics, it was interesting to know whether it might play a role in antibiotic prescribing and the use of rapid diagnostic tests in tonsillitis. On the one hand, RADTs decrease diagnostic uncertainty, by establishing that the tonsillitis is bacterial (group A streptococcal infection). One may hypothesise that risk-averse GPs might use RADTs more often, possibly as a way to decrease their diagnostic uncertainty. On the other hand, if GPs are not using RADTs, clinical findings do not allow to reliably differentiate between viral and bacterial tonsillitis.[@R3] Thus, one may hypothesise that risk-averse GPs might prescribe more antibiotics when they are not using RADTs since they may be more sensitive to diagnostic uncertainty than risk-tolerant GPs. Consequently, diagnostic uncertainty might lead here to unnecessary antibiotic prescriptions.

In this survey of a nationwide French representative sample of GPs, we wanted to assess the following hypotheses, taking tonsillitis as an example: (1) risk-averse GPs might use more RADTs, probably to decrease their diagnostic uncertainty regarding the aetiology of the disease (viral vs due to group A *Streptococcus*) and (2) GPs not using RADT might prescribe more antibiotics when they are risk averse.

Material and methods {#s2}
====================

Sampling {#s2a}
--------

A panel of French GPs was constituted in June 2010. Its procedures have already been described elsewhere.[@R4] Briefly, 5170 GPs were selected by random sampling from the Ministry of Health's exhaustive database of health professionals in France. Sampling was stratified for location of the general practice (urban, peri-urban or rural areas), gender, age (\<49, 49--56, \>56 years old) and the number of consultations (\<2849, 2849--5494, \>5494) in 2008. Of the 3888 contacted and eligible GPs, 1431 (36.8%) agreed to participate in the panel, that is, to provide regular data on their activity and respond to five consecutive surveys on different topics during a 30-month period. Among the 1136 GPs who participated in the fifth national cross-sectional survey, conducted in November 2012 (attrition rate between the first and fifth cross-sectional surveys: 20.6%), the results presented in this study are based on 1093 GPs (43 missing values).

Procedure and questionnaire {#s2b}
---------------------------

Professional investigators contacted the GPs and interviewed them with computer-assisted telephone interview software, using a standardised questionnaire (see online supplementary file). It collected information about their professional characteristics, their practices regarding tonsillitis and their individual risk attitudes in their daily life, concerning their personal finances and their medical behaviour regarding patients' health, using a Likert scale from 0 (not at all inclined to take risks) to 10 (totally inclined to take risks).[@R10] [@R11] We considered a scoring below 5 to be risk averse.[@R10] [@R11] From the questionnaire we studied the following indicators of compliance with tonsillitis guidelines: awareness and use of national tonsillitis guidelines (indicator 1, reflecting good practice); use of RADT in the last patient aged between 3 and 16 years presenting a tonsillitis (indicator 2, good practice); among GPs who declared using RADT, antibiotic prescription in case of a positive RADT result and absence of antibiotic prescription in case of a negative RADT result (indicator 3, good practice) and among GPs who did not use RADT, prescription of an antibiotic (indicator 4, reflecting poor practice).

Statistical analysis {#s2c}
--------------------

Owing to the panel participants' characteristics, we weighted the data to obtain a representative sample of the national French GP population for age, gender, location and volume of activity. For indicators 1 and 2, multivariate logistic regressions adjusted on the four stratification variables were performed, and for indicators 3 and 4 sample selection models in two steps were used to identify the risk domains associated with indicators of good or poor practice in order to take into account the selection effect of the sample. In the first step, the dependent variable was the use of RADTs; in the second step, the dependent variable was either indicator 3 or 4. The stratification variables were computed in the first step of the model. All indicators were studied separately in each multivariate analysis. All analyses were performed using SAS V.9.3.

Results {#s3}
=======

The sociodemographic characteristics of the participants are presented in [table 1](#BMJOPEN2013003540TB1){ref-type="table"}. A total of 69.4% of GPs were aware of national guidelines regarding tonsillitis and declared that they had taken these into account for their last tonsillitis case (indicator 1); 59.1% declared that they used RADT in their last patient aged between 3 and 16 years presenting with tonsillitis (indicator 2); 29.7% of these tests were positive and antibiotics were prescribed in 30.7% of the cases when RADT was used. Among the GPs who used RADT, 98.3% did either prescribe an antibiotic therapy because of a positive RADT result, or did not prescribe an antibiotic therapy in view of a negative result (indicator 3). Among the GPs who did not use RADT, 50.7% prescribed an antibiotic (indicator 4).

###### 

Sociodemographic characteristics of the 1093 general practitioners (GPs)

                                                                 Per cent
  -------------------------------------------------------------- ----------
  GPs' characteristics                                           
   Gender                                                        
    Male                                                         73.0
    Female                                                       27.0
   Age (years)                                                   
    \<45                                                         21.2
    45--54                                                       36.3
    \>54                                                         42.5
  Medical practice characteristics                               
   Location of practice                                          
    Urban                                                        21.0
    Peri-urban                                                   18.5
    Rural                                                        60.5
   Volume of activity (number of annual consultations)           
    \<2849                                                       20.6
    2849--5494                                                   54.3
    \>5494                                                       25.1
  Indicators of good practice                                    
   Awareness and use of tonsillitis guidelines                   
    Yes                                                          69.4
    No                                                           30.6
   Use of RADT in the last patient                               
    Yes                                                          59.1
    No                                                           40.9
   Good antibiotic prescription practices among GPs using RADT   
    Yes                                                          98.3
    No                                                           1.7
  Indicator of poor practice                                     
   Antibiotic prescriptions among GPs not using RADT             
    Yes                                                          50.7
    No                                                           49.3
  GPs' risk attitudes                                            
   Daily life                                                    
    Risk-averse                                                  40.1
    Risk-tolerant                                                57.2
    No answer\*                                                  2.7
   Medical behaviour regarding patients' health                  
    Risk-averse                                                  64.5
    Risk-tolerant                                                32.3
    No answer                                                    3.2
   Personal finances                                             
    Risk-averse                                                  56.4
    Risk-tolerant                                                40.3
    No answer                                                    3.3

\*Corresponds to GPs who chose not to answer the question, and to GPs who answered « I do not know ».

RADT, Rapid Antigen Diagnostic Test.

Individual risk attitudes {#s3a}
-------------------------

The prevalence of risk-averse GPs for the three following domains was as follows: 40.1% for the daily life scale, 56.4% for the personal finances one and 64.5% for the medical behaviour regarding patients' health scale.

Association between practices and individual risk attitudes {#s3b}
-----------------------------------------------------------

Risk-averse GPs declared being more aware of and compliant with guidelines, and used RADTs more often in their last patient. Among GPs not using RADT in their last patient, risk-averse GPs prescribed more antibiotics compared with risk-tolerant doctors ([table 2](#BMJOPEN2013003540TB2){ref-type="table"}).

###### 

Association between declared practices regarding tonsillitis and individual risk attitudes, in multivariate analysis (N=1093)

  Variables                  Percentage   aOR            Percentage   aOR            Percentage   aOR            Percentage   aOR
  -------------------------- ------------ -------------- ------------ -------------- ------------ -------------- ------------ ----------------
  GPs' characteristics                                                                                                        
   Gender                                                                                                                     
    Male                     66.6         1              55.2         1              98.0         1              54.3         1
    Female                   76.9         **1.46\***     69.8         **1.58\*\***   99.0         **1.28\*\***   36.1         **1.32\*\*\***
   Age                                                                                                                        
    \<45                     78.6         1.35           75.1         **1.79\*\***   100          **1.35\*\***   37.0         **1.32\*\***
    45--54                   72.1         1              60.5         1              97.6         1              44.3         1
    \>54                     62.4         **0.69\***     50.0         **0.67\*\***   97.9         **0.76\*\***   58.4         **0.73\*\*\***
   Location of practice                                                                                                       
    Urban                    65.9         0.91           60.3         1.28           99.6         1.16           54.9         1.09
    Peri-urban               73.4         1.24           66.9         **1.59\*\***   99.3         **1.29\*\***   50.7         **1.22\***
    Rural                    69.3         1              56.4         1              97.5         1              49.3         1
   Volume of activity                                                                                                         
    \<2849                   66.8         0.82           54.6         **0.69\***     98.6         **0.78\***     49.9         0.82
    2849--5494               70.7         1              63.2         1              98.4         1              51.4         1
    \>5494                   68.6         0.98           54.1         0.75           98.0         **0.82\***     50.1         0.89
  Domains of risk-aversion                                                                                                    
   Daily life                                                                                                                 
    Risk-averse              69.7         0.96           60.4         0.94           97.8         0.76           54.1         **1.18\***
    Risk-tolerant            68.7         1              58.6         1              98.7         1              49.5         1
    No answer                78.9         1.50           51.9         0.67           100          1.2            30.4         1.43
   Patients' health                                                                                                           
    Risk-averse              72.6         **1.56\*\***   69.9         0.99           99.4         **1.67\*\***   48.1         0.93
    Risk-tolerant            61.5         1              57.9         1              96.0         1              56.8         1
    No answer                83.0         **2.90\***     55.7         0.83           100          1.9            38.9         0.67
   Personal finances                                                                                                          
    Risk-averse              72.8         **1.45\*\***   62.7         **1.30\***     98.4         0.99           50.7         1.11
    Risk-tolerant            64.2         1              55.1         1              98.1         1              51.4         1
    No answer                73.6         1.46           48.2         0.71           100          0.75           42.6         0.68

\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.

†Sample selection models in two steps were performed to take into account the selection effect of the sample; for these models, all three domains of risk were entered in the model 1 by 1. Adjusted ORs cannot be obtained directly from these models, but they were calculated from the marginal effects.

aOR in bold typeface indicates statistically significant results (p\<0.05).

aOR, adjusted OR; GP, general practitioner; RADT, Rapid Antigen Diagnostic Test.

GPs' sociodemographic characteristics also influenced practices: for example, female GPs and GPs \<45 years old used RADTs more often in their last patient, but prescribed more antibiotics when RADT was not used. GPs with a low volume of activity also used RADTs less often.

Discussion {#s4}
==========

Our two hypotheses were verified: we found that risk-averse GPs were using RADTs more often and that a risk-averse behaviour was associated with an increase in antibiotic prescriptions when RADTs were not used. It is possible that the diagnostic uncertainty leading to unnecessary antibiotic prescriptions in tonsillitis leaves room for an increased use of RADTs and, as a consequence, for a decreased use of antibiotics in risk-averse GPs using RADT. RADTs may indeed decrease diagnostic uncertainty, as suggested in the literature.[@R6; @R7; @R8; @R9] [@R12] RADTs allow the physician to differentiate between viral and bacterial (group A streptococcal infection) tonsillitis, whereas clinical findings do not allow a reliable distinction to be made between viral and bacterial tonsillitis.[@R3] These tests are thus a very useful strategy to decrease unnecessary antibiotic prescriptions. Since the financial risk domain was associated with indicators 1 and 2, financial incentives regarding RADT use, included in a pay-for-performance programme, might have an impact on practices.

Our study states original findings, and is the first, to the best of our knowledge, to have assessed the individual risk attitudes of physicians using a standardised measure scale. It is based on declarative data, and not on real practices, and this could be a limitation; however, standardised questions allowed us to assess the true impact of risk attitudes. Furthermore, clinical vignettes have been shown to be a valid tool for measuring the quality of physician practice.[@R13] Finally, our results might not be generalisable to other countries, since France is known for its high uncertainty avoidance score, which could be a possible driver behind the observed behaviour.[@R6] [@R7]

In conclusion, RADTs for tonsillitis can reduce unnecessary antibiotic prescriptions, possibly because they decrease diagnostic uncertainty regarding the aetiology of tonsillitis. Risk aversion has a dual effect: on the one hand, it induces GPs to use more RADTs (and as a consequence to prescribe less antibiotics), whereas on the other it also induces GPs to prescribe more antibiotics when RADTs are not used.
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